Argus Partners advises MedGenome on ~₹400 crore Series E fundraise

MedGenome Inc. has raised ~₹400 crore ($47.5 million) from a Series E fundraise co-led by Maj Invest and existing investor Novo Holdings, with participation from Sofina Ventures.

Argus Partners advised MedGenome on this fundraise.

The transaction team consisted of Abhinav Bhalaik (Partner), Armaan Patkar (Partner), Ishita Agarwal (Senior Associate) and Anoushka Goel (Associate).

MedGenome is a genomic diagnostics and research services company.

The fundraise will enable MedGenome to broaden access to its genomics and integrated diagnostics solutions across India and other emerging markets. The funding will further strengthen MedGenome’s efforts to reduce India’s disease burden through early detection and targeted disease management using affordable, genetics-based diagnostic tools.

If you would like your Deals, Columns, Press Releases to be published on Bar & Bench, please fill in the form available here.